Serum adipokines as non‑invasive biomarkers in Crohn’s disease

dc.contributor.authorOrtega Moreno, Lorena
dc.contributor.authorSanz García, Ancor
dc.contributor.authorFernández de la Fuente, Marina J
dc.contributor.authorArroyo Solera, Ricardo
dc.contributor.authorFernández-Tomé, Samuel
dc.contributor.authorMarin, Alicia C
dc.contributor.authorMora-Gutierrez, Irene
dc.contributor.authorFernández, Paloma
dc.contributor.authorBaldan-Martin, Montse
dc.contributor.authorChaparro, María
dc.contributor.authorGisbert, Javier P.
dc.contributor.authorBernardo, David
dc.date.accessioned2023-11-24T11:27:20Z
dc.date.available2023-11-24T11:27:20Z
dc.date.issued2020
dc.description.abstractAdipose tissue secretes molecules that can promote activity in Crohn’s disease. We aimed to evaluate the role of serum adipokines as possible biomarkers in Crohn’s disease. Serum samples were obtained from 40 patients with endoscopically active or quiescent Crohn’s disease and 36 healthy controls. Serum leptin, ghrelin, resistin and adiponectin levels were analysed by Multiplex in a Luminex 200 system technology. Receiver Operating Characteristic curves were performed to evaluate the adipokines discriminatory capacity. A logistic regression adjusted by possible confounders (i.e. gender, age, BMI) was performed for those adipokines that showed an area under the curve> 0.7. No diferences were found in age, gender or BMI among groups. Distribution for serum resistin was diferent among the three groups of study, and only this adipokine showed an area under the curve of 0.75 comparing actives patients and healthy control groups. Resistin median concentration was selected as a cut-of for a logistic regression analysis; odds ratio along its 95% confdence interval adjusted by gender, age, and BMI yielded a value of 5.46 (1.34–22.14) comparing actives patients and healthy controls. High concentration of serum resistin is probably associated to activity, being this association independent of gender, age or BMI.
dc.description.urihttps://doi.org/10.1038/s41598-020-74999-6
dc.identifier.citationOrtega Moreno, L., Sanz-Garcia, A., Fernández de la Fuente, M.J. et al. Serum adipokines as non-invasive biomarkers in Crohn’s disease. Sci Rep 10, 18027 (2020). https://doi.org/10.1038/s41598-020-74999-6
dc.identifier.doi10.1038/s41598-020-74999-6es
dc.identifier.urihttps://hdl.handle.net/10115/26419
dc.rightsAttribution 4.0 International
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleSerum adipokines as non‑invasive biomarkers in Crohn’s diseasees
dc.typeinfo:eu-repo/semantics/articlees

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Ortegamoreno2020.pdf
Tamaño:
1.27 MB
Formato:
Adobe Portable Document Format
Descripción:

Bloque de licencias

Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
2.67 KB
Formato:
Item-specific license agreed upon to submission
Descripción: